Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8597684 Modified release formulations containing drug-ion exchange resin complexes

Patent 8597684 was granted and assigned to Tris Pharma on December, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

December 3, 2013

0

Patent Application Number

137466540

Date Filed

January 22, 2013

0

Patent Citations Received

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115143 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US Patent 11839597 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 11890267 Benzonatate modified release solid tablets and capsules

0

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8597684 Modified release formulations containing drug-ion exchange resin complexes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool